Bm. Sartor et al., ANALOGOUS TAMOXIFEN AND ESTROGEN EFFECTS ON TRANSFORMING GROWTH-FACTOR-BETA-1 AND GROWTH-FACTOR-BETA-2 IN THE RAT UTERUS, Reproductive toxicology, 9(3), 1995, pp. 225-231
Estrogenic stimulation is a potent risk factor for the development of
uterine cancer. More recently, analysis of patients in prospective bre
ast cancer trials have established that tamoxifen also increases uteri
ne cancer risk. In this report, uteri of oophorectomized rats were exa
mined to ascertain the effects of estrogen and tamoxifen on the uterin
e induction of two isoforms of transforming growth factor-beta (TGF-be
ta). In contrast to studies of cells derived from breast epithelium, o
ur studies reveal that both estrogen and tamoxifen increase immunoreac
tive TGF-beta. These changes were particularly pronounced in the endom
etrial stroma. Effects of progesterone also were examined and found to
be distinct and relatively restricted to the glandular epithelium. Th
ese studies indicate that, in the uteri of oophorectomized rats, tamox
ifen exerts estrogen-like effects on a peptide previously implicated i
n the control of cellular growth and differentiation. We hypothesize t
hat induction of TGF-beta isoforms may be an important mediatior of bo
th estrogen- and tamoxifen-induced proliferative disorders in the uter
us.